West Bengal, India

Pralay Das

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pralay Das. Retrieved from https://idiyas.com/inventor/pralay-das-z8h39cfn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,570 
Other
 patents

Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pralay Das: Innovator in Peptidomimetic Compounds

Introduction

Pralay Das is a notable inventor based in West Bengal, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential therapeutic applications.

Latest Patents

Pralay Das holds a patent for peptidomimetic compounds. The present invention relates to new compounds of the formula (I), (II), or (III) wherein R, R, R, R, R, and W are as defined herein. These compounds are part of pharmaceutical compositions that can be used in the treatment of amyloid diseases, especially Aβ amyloid disease, which is observed in Alzheimer's disease, infectious diseases, and PAI-I related diseases. The invention also encompasses the manufacture of medicaments for such treatments.

Career Highlights

Throughout his career, Pralay Das has focused on innovative solutions in the pharmaceutical industry. His work has led to advancements in the understanding and treatment of complex diseases, showcasing his commitment to improving healthcare outcomes.

Collaborations

Pralay Das has collaborated with notable professionals in his field, including Fredrik Almqvist and Magnus Sellstedt. These partnerships have contributed to the development and refinement of his innovative compounds.

Conclusion

Pralay Das is a distinguished inventor whose work in peptidomimetic compounds holds promise for the treatment of amyloid diseases. His contributions to the pharmaceutical field reflect his dedication to advancing medical science and improving patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…